Empowered Funds LLC lessened its position in shares of American Vanguard Co. (NYSE:AVD – Free Report) by 42.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,268 shares of the basic materials company’s stock after selling 27,647 shares during the period. Empowered Funds LLC owned approximately 0.13% of American Vanguard worth $173,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC bought a new stake in shares of American Vanguard during the 3rd quarter worth approximately $56,000. Quantbot Technologies LP lifted its holdings in shares of American Vanguard by 64.5% during the 3rd quarter. Quantbot Technologies LP now owns 11,291 shares of the basic materials company’s stock worth $60,000 after acquiring an additional 4,429 shares during the period. Quantinno Capital Management LP bought a new position in American Vanguard in the 3rd quarter valued at approximately $89,000. XTX Topco Ltd bought a new position in American Vanguard in the 3rd quarter valued at approximately $104,000. Finally, PDT Partners LLC bought a new position in American Vanguard in the 3rd quarter valued at approximately $130,000. Institutional investors own 79.04% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, Lake Street Capital set a $14.00 price objective on shares of American Vanguard in a research note on Tuesday, January 21st.
American Vanguard Price Performance
Shares of NYSE:AVD opened at $5.29 on Friday. The company has a market cap of $152.17 million, a price-to-earnings ratio of -5.13 and a beta of 0.94. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.89 and a quick ratio of 0.79. The firm has a 50 day simple moving average of $5.15 and a 200 day simple moving average of $5.51. American Vanguard Co. has a one year low of $4.26 and a one year high of $14.28.
American Vanguard Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Featured Stories
- Five stocks we like better than American Vanguard
- How to Invest in Small Cap StocksÂ
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Do ETFs Pay Dividends? What You Need to Know
- DuPont’s Electronics Spinoff: The Start of Something Big
- What is the Dogs of the Dow Strategy? Overview and Examples
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding AVD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Vanguard Co. (NYSE:AVD – Free Report).
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.